New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...

Louisiana is facing a significant obesity challenge, ranking fourth in the nation for obesity rates. As a result, many residents are turning to weight loss drugs like ...

It’s the hot-shot fix that took Hollywood — and now high school — by storm. Ozempic and other so-called “miracle” weight-loss ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

GLP-1 weight loss drugs, such as Wegovy and Zepbound, have helped millions of people shed weight and curb food cravings. But they create additional health problems, Kessler says, and there's not ...

Weight loss drugs are just another reminder that it's easier to sell us stuff when skinniness is the default mode.

Teens are being prescribed Ozempic more than ever before — and some doctors are worried about what the trend could mean.

AHCA/NCAL helps shape and execute federally-funded research across the country that will deliver solutions to our members.

In an age where quick fixes are often sought over true solutions, the rise of GLP-1 receptor agonists like Ozempic has sparked serious concerns about the hidden dangers of these weight-loss ...